Case studies

How healthcare organisations are tackling cybersecurity challenges

Credit: Bert van Dijk/Getty images.

Powered by

The NotPetya attack on Merck & Co

In 2017, a Russian malware attack disabled 30,000 of Merck & Co’s computers and stopped its operations for two weeks. Merck estimated the damages at $1.4 billion. NotPetya, the malware employed in the attack, penetrated Microsoft systems that lacked a security patch.  

The damages included a loss of approximately $260 million in global drug sales in 2017, as Merck could not fulfill orders for products in certain markets. Expenses related to manufacturing and remediation efforts totaled $285 million in 2017. Additionally, the company’s 2018 drug sales were negatively impacted by approximately $200 million due to a residual backlog of drug orders.  

Merck was also unable to meet the demand for Gardasil 9, a vaccine against the human papillomavirus, due to the temporary production shutdown. As such, it borrowed Gardasil 9 from the US Center for Disease Control and Prevention’s (CDC’s) Pediatric Vaccine Stockpile. Merck replenished some of the borrowed doses in 2017, costing the company $125 million.  

Merck’s cyber insurer, Ace American, refused to cover the breach because the attack was part of an “act of war”, as the malware was created by the Russian military in 2017 to target Ukraine. Merck sued its insurance companies, and the New Jersey Superior Court ruled in Merck’s favor in December 2021. The company received a $1.4 billion payout. In early January 2024, Merck settled with other insurers. 

Many healthcare insurers have consequently updated their clauses around cyberattacks and acts of war.

Palo Alto Networks launches a zero-trust security solution

In 2023, Palo Alto Networks, a US cybersecurity company, launched its zero-trust security solution for medical devices, Medical IoT Security. Zero trust is a cybersecurity framework and approach that removes the assumption of implicit trust in an organization. Employees must validate their credentials at multiple stages of digital interaction with a company’s applications. Zero trust always assumes an entity is untrustworthy until its credentials are verified. Zero trust adoption is increasing, and many view it as a long-term solution for organizations to protect themselves against cybersecurity breaches.   

The solution is intended to help healthcare organizations deploy and manage connected devices safely and easily. It uses ML to allow healthcare facilities to develop rules to monitor devices for behavioral anomalies, ultimately initiating the proper response. It automates zero trust policy recommendations for medical devices while also allowing the organization to access the software bill of materials (SBOM) for each medical device and map them to common vulnerability exposures. The solution further offers the risk profile of each device, including the end-of-life status, recall notifications, default password alerts, and potential for unauthorized communication with external websites. Healthcare facilities can visualize the connected devices and ensure that each is positioned in the appropriate network segment.   

Palo Alto Networks medical IoT tool aims to address the increasing cybersecurity demands within the medical devices sector by incorporating intelligence. The ultimate goal of this solution is to improve the patient and practitioner experience and bring devices into compliance with rules and regulations, such as HIPAA. The solution can be used with various healthcare information management systems to ensure use across multiple connected devices.

Milton Keynes Hospital uses Darktrace’s unsupervised artificial intelligence cybersecurity system

Milton Keynes University Hospital NHS Foundation Trust wanted to improve its cybersecurity approach, as attacks against hospitals were becoming increasingly sophisticated and common. The 2017 WannaCry ransomware attack on the NHS systems caused widespread disruption by encrypting patient data and rendering computer systems unusable, showcasing the need for cybersecurity in hospitals.  

The Milton Keynes Hospital decided to work with UK cybersecurity vendor Darktrace. The company offers unsupervised AI as part of its cybersecurity solutions, specifically in its Enterprise Immune System. Unsupervised AI refers to a type of ML algorithm that analyzes and clusters unlabeled datasets to discover hidden patterns or data groupings without human intervention.  

Unlike supervised learning, which uses labeled input and output data, unsupervised learning algorithms do not require pre-determined outputs and instead find similarities, patterns, or data groupings between data points. 

This system uses unsupervised ML to analyze normal work patterns across a client's digital environments, including the cloud, email, and IoT devices. It continuously monitors data flow across various platforms and learns on the job from everyday data, allowing it to identify and thwart cyber threats before they become a crisis.  

There are significant advantages to using Darktrace's unsupervised AI approach compared to traditional methods that rely on rules, signatures, and blacklists. Traditional methods often require prior set-up and can only detect known threats that they have been trained to recognize.  

However, Darktrace's unsupervised AI approach can combat novel cyber threats by establishing a baseline of normal behavior and identifying any anomalies without relying on pre-labeled data. This allows the system to detect and respond to emerging threats at the earliest stages, reducing the organization's downtime and resources required for IT security.   

By decreasing digital downtime, hospitals could improve patient care, increase operational efficiency, and reduce the risk of medical errors. Furthermore, the capacity that Darktrace’s system has to constantly be on watch has increased the capacity of the hospital’s security team, which can now be dedicated to other activities. 

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Thematic Intelligence uses proprietary data, research, and analysis to provide a forward-looking perspective on the key themes that will shape the future of the world’s largest industries and the organisations within them. 

Go to article: Home | Left in limbo: When pharma halts rare disease researchGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: FaravelliGo to article: In DepthGo to article: Left in limbo: When pharma halts rare disease research Go to article: Capturing the genAI boom for drug developmentGo to article: Too much data: a burden or a blessing? Go to article: South Korea seeks to accelerate drug reimbursement administration process Go to article: Sponsors must take on FDA’s diversity guidance to improve community trust Go to article: DelSiTech Company InsightGo to article: Thematic Take: CybersecurityGo to article: Thematic Take: contentsGo to article: Foreword: Cybersecurity in the age of AI Go to article: Navigating the AI-driven cybersecurity landscapeGo to article: Key trends impacting cybersecurity Go to article: Timeline: a history of cybersecurity Go to article: Explainer: The most common types of cyberattacks Go to article: The impact of cybersecurity on healthcareGo to article: Case studies: cybersecurity in healthcare Go to article: Leading cybersecurity adopters and providers in healthcareGo to article: AI attacks now ‘the main cybersecurity concern’ for businesses across sectors Go to article: The state of cybersecurity: AI and geopolitics mean a bigger threat than ever Go to article: Companies’ own AI applications are ‘a huge cybersecurity problem’ Go to article: How healthcare cybercrime is predicted to escalate Go to article: The lasting impacts of the pandemic on cybersecurity in healthcare Go to article: Cyberattacks on healthcare: Russia’s tool for mass disruption Go to article: Traceability technologies tighten supply chain fakery Go to article: Deal activity related to cybersecurity in the pharma industry since 2021 Go to article: Regulators must protect the cybersecurity market from a private equity takeover Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: XylemGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue